Life sciences company Danaher (DHR) delivered a first-quarter earnings beat Tuesday, even as its lowered outlook sent shares of the Club holding tumbling.
You are here: Home / Danaher’s disappointing guidance weighs on the stock — and forces us to reassess our investment case